Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
4
×
boston blog main
boston top stories
life sciences
national blog main
biotech
national top stories
europe blog main
europe top stories
roche
san francisco blog main
allergan
alnylam pharmaceuticals
amy schulman
andreas klein
anna greka
avapritinib
barry greene
biopharma
blueprint medicines
cancer
cancer drugs
capmatinib
car-t
caron jacobson
cigall kadoch
clinical trials
craig mello
crispr
cynthia collins
dan ollendorf
deals
drugs
duchenne
editas medicine
eli lilly
events
foghorn therapeutics
gastrointestinal stromal tumors
gene editing
What
therapy
4
×
gene
approval
fda
medicine
medicines
rna
address
allergan
approves
aren’t
betting
billion
biopharma
blessing
blueprint
bosley
cancer
car
carries
ceo
certain
check
clinical
crispr
cusp
cutting
deal
depart
designed
drug
duchenne
edge
editas
editing
experimental
experiments
genetic
historic
hot
Language
unset
Current search:
therapy
×
boston
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
